The Anti-Arthritic and Immune-Modulatory Effects of NHAG: A Novel Glucosamine Analogue in Adjuvant-Induced Arthritis

Table 2

Individual gait parameters measured on day 0 and day 20. The values are expressed as the mean ± SEM (𝑛=12), where (*) designates (𝑃<0.02) compared to arthritic control animals.

Treatment Group	Day	Speed (cm/sec)	Stride length (cm)	Stance time (s)	Swing time (s)
Normal control	0	24.16 ± 0.37	15.05 ± 0.26	5.40 ± 0.01	2.89 ± 0.005
	20	30.66 ± 0.72*	15.11 ± 0.24*	4.93 ± 0.01*	2.49 ± 0.005*
Arthritic control	0	25.28 ± 0.99	14.24 ± 0.48	5.54 ± 0.02	2.59 ± 0.021
	20	19.31 ± 1.04	10.68 ± 0.44	7.64 ± 0.02	4.43 ± 0.025
Drug control (5 mg/kg)	0	26.09 ± 1.0	12.76 ± 0.77	5.03 ± 0.01	2.99 ± 0.019
	20	23.69 ± 0.54*	13.41 ± 0.28*	6.23 ± 0.03*	3.25 ± 0.008*
NHAG + arthritis (5 mg/kg)	0	23.53 ± 0.49	12.73 ± 0.43	5.29 ± 0.01	3.07 ± 0.018
	20	24.01 ± 0.66*	12.76 ± 0.11*	6.52 ± 0.03*	2.89 ± 0.006*